Kidney Failure Caused by Covid-19 and Kidney Failure Caused by Other Causes
Keywords:
Kidney failure, COVID-19, renal insufficiency, CKD, SARS-CoV-2
Abstract
The current study, which included a statistical collection of patients infected with Corona virus who had complications due to infection with this virus and those with kidney failure as a result of complications from the pandemic, was conducted in the dialysis department of Al-Hussein Teaching Hospital in Thi Qar Governorate for the period from January to August of 2021. The study explained ,that the percentage of males exposed to kidney failure was higher than the percentage of females, according to the statistic that was conducted in the dialysis department of Al Hussein Teaching Hospital in Dhi Qar Governorate. And the age range ranged from 40 to 86 years for patients exposed to kidney failure as a result of complications caused by infection with Covid, which takes a sharp curve due to lack of awareness or failure to give appropriate treatment for this virus or due to an immune defect in the patient. Which led to several complications, including kidney failure due to the virus reaching the kidney membrane of patients.
References
1. Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long covid. Journal of the American Society of Nephrology. 2021 .the Johns Hopkins Division of Nephrology.
2. Zhou L et al (2020) SARS-CoV-2 viral load in upper respiratory specimensof infected patients. N Engl J Med382(12):1177–1179.
3. Puelles VG et al (2020) Multiorgan and re- nal tropism of SARS-coV-2. N Engl J Med 383(6):590–592. https://doi.org/10.1056/ NEJMc201140.
4. Gavriatopoulou M et al (2020) Organ-specific manifestations of COVID-19 infection. Clin Exp Med. https://doi.org/10.1007/s10238-020- 00648-x.
5. Allison SJ (2020) SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2. Nat Rev Nephrol 16(6):316. https://doi.org/10. 1038/s41581-020-0291-8.
6. Rubin S et al (2020) Characterization of acute kidney injury in critically ill patients with se-vere coronavirus disease 2019. Clin Kidney J 13(3):354–361.
7. BM Curtis, et al. Nephrol Dial Transplant 20: 147, 2005.
8. M Moser, et al. NEJM 355: 385, 2006.
9. LE Boulware, et al. Am J Kidney Dis 48: 192, 2006.
10. RichardsonSetal(2020) Presentingcharacteristics, comorbidities,andoutcomesamong5700patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059 .
11. Zhou F et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan,China: a retrospectivecohort study. Lancet 395(10229):1054–1062.
12. Cheng Y et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. KidneyInt97(5):829–838.
13. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17(11):3067–3075. doi:10.1681/ASN.2006050423.
14. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem fi ndings of patients with COVID-19 in China. Kidney Int 2020; 98(1):219–227. doi:10.1016/j.kint.2020.04.003.
15. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97(5):829–838. doi:10.1016/j.kint.2020.03.005.
16. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5):475–481. doi:10.1016/S2213-2600(20)30079-5.
17. Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 2005; 75(2):185–194. doi:10.1002/jmv.20255.
18. Chen LL, Hsu CW, Tian YC, Fang JT. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract 2005; 59(10):1162–1166. doi:10.1111/j.1368-5031.2005.00540.x
19. Wang JL, Wang JT, Yu CJ, et al. Rhabdomyolysis associated with probable SARS. Am J Med 2003; 115(5):421–422. doi:10.1016/s0002-9343(03)00448-0
20. Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323(16):1612–1614. doi:10.1001/jama.2020.4326.
21. Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 2020; 31(6):1157–1165. doi:10.1681/ASN.2020030276.
22. Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020; 98(1):209–218. doi:10.1016/j.kint.2020.05.006.
23. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinicalcourse, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020; 395(10239):1763– 1770. doi:10.1016/S0140-6736(20)31189-2.
24. Fisher M, Neugarten J, Bellin E, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol 2020. [Epub ahead of print] doi:10.1681/ASN.2020040509.
25. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336: 1475–1482.
2. Zhou L et al (2020) SARS-CoV-2 viral load in upper respiratory specimensof infected patients. N Engl J Med382(12):1177–1179.
3. Puelles VG et al (2020) Multiorgan and re- nal tropism of SARS-coV-2. N Engl J Med 383(6):590–592. https://doi.org/10.1056/ NEJMc201140.
4. Gavriatopoulou M et al (2020) Organ-specific manifestations of COVID-19 infection. Clin Exp Med. https://doi.org/10.1007/s10238-020- 00648-x.
5. Allison SJ (2020) SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2. Nat Rev Nephrol 16(6):316. https://doi.org/10. 1038/s41581-020-0291-8.
6. Rubin S et al (2020) Characterization of acute kidney injury in critically ill patients with se-vere coronavirus disease 2019. Clin Kidney J 13(3):354–361.
7. BM Curtis, et al. Nephrol Dial Transplant 20: 147, 2005.
8. M Moser, et al. NEJM 355: 385, 2006.
9. LE Boulware, et al. Am J Kidney Dis 48: 192, 2006.
10. RichardsonSetal(2020) Presentingcharacteristics, comorbidities,andoutcomesamong5700patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059 .
11. Zhou F et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan,China: a retrospectivecohort study. Lancet 395(10229):1054–1062.
12. Cheng Y et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. KidneyInt97(5):829–838.
13. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17(11):3067–3075. doi:10.1681/ASN.2006050423.
14. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem fi ndings of patients with COVID-19 in China. Kidney Int 2020; 98(1):219–227. doi:10.1016/j.kint.2020.04.003.
15. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; 97(5):829–838. doi:10.1016/j.kint.2020.03.005.
16. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5):475–481. doi:10.1016/S2213-2600(20)30079-5.
17. Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 2005; 75(2):185–194. doi:10.1002/jmv.20255.
18. Chen LL, Hsu CW, Tian YC, Fang JT. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract 2005; 59(10):1162–1166. doi:10.1111/j.1368-5031.2005.00540.x
19. Wang JL, Wang JT, Yu CJ, et al. Rhabdomyolysis associated with probable SARS. Am J Med 2003; 115(5):421–422. doi:10.1016/s0002-9343(03)00448-0
20. Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323(16):1612–1614. doi:10.1001/jama.2020.4326.
21. Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 2020; 31(6):1157–1165. doi:10.1681/ASN.2020030276.
22. Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020; 98(1):209–218. doi:10.1016/j.kint.2020.05.006.
23. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinicalcourse, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020; 395(10239):1763– 1770. doi:10.1016/S0140-6736(20)31189-2.
24. Fisher M, Neugarten J, Bellin E, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol 2020. [Epub ahead of print] doi:10.1681/ASN.2020040509.
25. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336: 1475–1482.
Published
2023-02-28
How to Cite
Slman, Z. A. R., Jabbar, T. S., & Maili, A. Q. (2023). Kidney Failure Caused by Covid-19 and Kidney Failure Caused by Other Causes. Central Asian Journal of Medical and Natural Science, 4(1), 360-368. https://doi.org/10.17605/cajmns.v4i1.1346
Section
Articles
